Research graph
References from Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21590
10.3322/caac.21590 · External reference
10.1038/s41575-018-0005-x
10.1038/s41575-018-0005-x · External reference
Cancer immunotherapy comes of age
10.1038/ncponc0101 · 2005 · External reference
10.1097/cji.0b013e3181eec14c
10.1097/cji.0b013e3181eec14c · External reference
10.1093/annonc/mdw168
10.1093/annonc/mdw168 · External reference
10.1158/1078-0432.ccr-16-2318
10.1158/1078-0432.ccr-16-2318 · External reference
10.1158/2326-6066.cir-16-0322
10.1158/2326-6066.cir-16-0322 · External reference
10.1186/s13045-019-0770-1
10.1186/s13045-019-0770-1 · External reference
10.1038/s41568-019-0238-1
10.1038/s41568-019-0238-1 · External reference
10.1172/jci94624
10.1172/jci94624 · External reference
10.1073/pnas.1815515116
10.1073/pnas.1815515116 · External reference
10.1038/oncsis.2016.7
10.1038/oncsis.2016.7 · External reference
10.3390/ijms150712928
10.3390/ijms150712928 · External reference
Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis
10.1172/jci.insight.122375 · 2018 · External reference
10.1038/s41573-018-0004-1
10.1038/s41573-018-0004-1 · External reference
10.1016/j.cellimm.2017.12.003
10.1016/j.cellimm.2017.12.003 · External reference
10.1186/s12943-021-01428-1
10.1186/s12943-021-01428-1 · External reference
10.1056/nejmoa1200690
10.1056/nejmoa1200690 · External reference
FGFR4 inhibitor BLU9931 attenuates pancreatic cancer cell proliferation and invasion while inducing senescence: evidence for senolytic therapy potential in pancreatic cancer
10.3390/cancers12102976 · 2020 · External reference
10.1006/bbrc.1999.0465
10.1006/bbrc.1999.0465 · External reference
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7
10.1111/cas.12745 · 2015 · External reference
10.1093/nar/gkaa1020
10.1093/nar/gkaa1020 · External reference
10.1111/imr.12978
10.1111/imr.12978 · External reference
10.1038/onc.2016.353
10.1038/onc.2016.353 · External reference
10.1158/2159-8290.cd-19-0094
10.1158/2159-8290.cd-19-0094 · External reference
10.1111/imr.12982
10.1111/imr.12982 · External reference
10.1038/s41580-018-0080-4
10.1038/s41580-018-0080-4 · External reference
Unraveling cell-cycle dynamics in cancer
10.1016/j.cels.2016.01.007 · 2016 · External reference
Oncogenic roles of the PI3K/AKT/mTOR axis
2017 · External reference
The immune microenvironment in pancreatic cancer
10.3390/ijms21197307 · 2020 · External reference
10.1038/s41575-020-0300-1
10.1038/s41575-020-0300-1 · External reference
Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma
2011 · External reference
Lenvatinib targets FGF receptor 4 to enhance antitumor immune response of anti-programmed cell death-1 in HCC
10.1002/hep.31921 · 2021 · External reference
